Delayed-release drugs for the treatment of knee osteoarthritis – drugs of choice in a comorbid patient

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Osteoarthritis is the most common joint disease in adults. Statistical data allow to talk about a constant increase in the number of patients suffering from this disease. Despite progress in understanding the pathogenesis of the disease, osteoarthritis remains an incurable pathology. Additional difficulties may arise in the presence of concomitant pathology in a patient, limiting the intake, in particular, of non-steroidal anti-inflammatory drugs. The article presents modern approaches to the treatment of osteoarthritis, as well as clinical observation of a patient with comorbid pathology and the use of a delayed-release drug for its treatment.

Full Text

Restricted Access

About the authors

Daria Yu. Andriyashkina

Pirogov Russian National Research Medical University

Author for correspondence.
Email: andryashkina.darya@yandex.ru
ORCID iD: 0000-0001-8266-6022
SPIN-code: 1804-1274

Cand. Sci. (Med.), Associate Professor at the Department of Faculty Therapy n.a. Acad. A.I. Nesterov, Faculty of General Medicine

Russian Federation, Moscow

A. A. Klimenko

Pirogov Russian National Research Medical University

Email: andryashkina.darya@yandex.ru

Department of Faculty Therapy n.a. Academican A.I. Nesterov, Faculty of General Medicine

Russian Federation, Moscow

N. A. Demidova

Pirogov Russian National Research Medical University

Email: andryashkina.darya@yandex.ru

Department of Faculty Therapy n.a. Academican A.I. Nesterov, Faculty of General Medicine

Russian Federation, Moscow

A. A. Kondrashov

Pirogov Russian National Research Medical University

Email: andryashkina.darya@yandex.ru

Department of Faculty Therapy n.a. Academican A.I. Nesterov, Faculty of General Medicine

Russian Federation, Moscow

M. O. Anischenko

Pirogov Russian National Research Medical University

Email: andryashkina.darya@yandex.ru

Department of Faculty Therapy n.a. Academican A.I. Nesterov, Faculty of General Medicine

Russian Federation, Moscow

References

  1. Felson D.T. Epidemiology of knee and hip osteoarthritis. Epidemiol Rev. 1988;10:1–28. doi: 10.1093/oxfordjournals.epirev.a036019.
  2. Галушко Е.А. Медико-социальная значимость ревматических заболеваний. Дисс. докт. мед. наук. М., 2011. [Galushko E.A. Medico-social significance of rheumatic diseases. Diss. Doct. of Med. Sciences. M., 2011. (In Russ.)].
  3. Лила А.М., Лила В.А. Социальная значимость и экономические последствия ревматических заболеваний. Гигиена и санитария. 2017;96(4):387–92. [Lila A.M., Lila V.A. Social significance and economic consequences of rheumatic diseases. Gigiena i sanitariya. 2017;96(4):387–92. (In Russ.)].
  4. Лила А.М. Остеоартрит. Ревматология. Фармакотерапия без ошибок: руководство для врачей. Под ред. В.И. Мазурова, О.М. Лесняк. М., 2017. С. 351–78. [Lila A.M. Osteoarthritis. Rheumatology. Pharmacotherapy without errors: a guide for physicians. Ed. by V.I. Mazurov, O.M. Lesnyak. M., 2017. P. 351–78. (In Russ.)].
  5. Балабанова Р.М., Дубинина Т.В., Эрдес Ш.Ф. Динамика заболеваемости ревматическими заболеваниями взрослого населения России за 2010-2014 гг. Научно- практическая ревматология. 2016;54(3):266–70. [Balabanova R.M., Dubinina T.V., Erdes Sр.F. Trends in the incidence of rheumatic diseases in the adult population of Russia over 2010-2014. Nauchno-Prakticheskaya Revmatologiya=Rheumatology Science and Practice. 2016;54(3):266-70 (In Russ.)]. doi: 10.14412/1995-4484- 2016-266-270.
  6. Felson D.T., Couropmitree N.N., Chaisson C.E., et al. Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis. The Framingham Study. Arthr Rheum. 1998;41:1064–71. doi: 10.1002/1529-0131(199806)41:6<1064:: AID-ART13>3.0.CO;2-K.
  7. Andrianakos A.A., Kontelis L.K., Karamitsos D.G., et al. Prevalence of symptomatic knee, hand and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol. 2006;33:2507–13.
  8. Oliveria S.A., Felson D.T., Reed J.I., et al. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health maintenance organisation. Arthr Rheumat. 1995;38:1134–41. doi: 10.1002/art.1780380817.
  9. van Saase J.L.C.M., van Romunde L.K.J., Cats A., et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis. 1989;48:271–80. doi: 10.1136/ard.48.4.271.
  10. Hackenbroch M.H. Arthrosen. Georg Thieme Verlag. 2002.
  11. Otte P. Der Arthrose-Prozeß: Gelenkerhaltung – Gefahrdung – Destruktion. Teil 1: Osteochondrale Strukturen. Nurnberg: Novartis 2000.
  12. Mohing W. Die Arthrosis deformans des Kniegelenkes. SpringerVerlag. Berlin. 1966.
  13. Pendelton A.N., Arden N., Dougados M., et al.: EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCICIT). Ann Rheum Dis. 2000;59:936–44. doi: 10.1136/ard.59.12.936.
  14. Jordan K.M., Arden N.K., Doherty M., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–55. doi: 10.1136/ard.2003.011742.
  15. Chodosh J., Morton S.C., Mojica W., et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143:427–38. doi: 10.7326/0003-4819-143-6-200509200-00007.
  16. Fransen M., McConnell S., Bell M. Exercise for osteoarthritis of the hip or knee. Cochrane Database Syst Rev. 2001;2:CD004286. doi: 10.1002/14651858.CD004286.
  17. Bruyere O., Honvo G., Veronese N., et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthr Rheum. 2019;49(3):337–50. doi: 10.1016/j.semarthrit.2019.04.008.
  18. Федеральные клинические рекомендации по диагностике и лечению остеоартроза. [Federal clinical guidelines for the diagnosis and treatment of osteoarthritis. (In Russ.)]. URL: https://diseases.medelement.com/disease/остеоартроз-рекомендации-рф/15094?ysclid=lafu1u1rks364271331.
  19. Pollard H., Ward G., Hoskins W., Hardy K. The effect of a manual therapy knee protocol on osteoarthritis knee pain: a randomised controlled trial. J Can Chiropr Assoc. 2008;52:229–42.
  20. Richmond J., Hunter D., Irrgang J., et al. Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg. 2009;17:591–600. doi: 10.5435/00124635-200909000-00006.
  21. Алексеева Л.И., Лила А.М., Шарапова Е.П. и др. Многоцентровое проспективное наблюдательное исследование по применению препаратов Артра® МСМ форте и Артра® у пациентов с остеоартритом коленных и/или тазобедренных суставов и/или с болью в нижней части спины (предварительные результаты). Трудный пациент. 2018;16(6):34–41. [Alekseeva L.I., Lila A.M., Sharapova E.P. et al. Multicenter prospective observational study on the use of Artra® MSM forte and Artra® in patients with knee and/or hip osteoarthritis and/or low back pain (preliminary results). Trudnyi patsient. 2018;16(6):34–41. (In Russ.)].
  22. Yang K.G., Raijmakers N.J., van Arkel E.R., et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthr Cartilage. 2008;16:498–505. doi: 10.1016/j.joca.2007.07.008.
  23. Joern W.-P., et al. The Epidemiology, Etiology, Diagnosis, and Treatment of Osteoarthritis of the Knee. Dtsch Arztebl Int. 2010;107(9):152–62. doi: 10.3238/arztebl.2010.0152.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig.

Download (125KB)
Indexing metadata

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies